Immuron (IMRN) Asset Writedowns and Impairment (2016 - 2017)
Immuron (IMRN) recorded quarterly Asset Writedowns and Impairment of -$127500.4 in Q4 2017, down 25.1% quarter-over-quarter from -$101915.2 in Q4 2016, and down 25.1% on a YoY basis from -$170237.6 in Q4 2016.
Immuron (IMRN) Asset Writedowns and Impairment (2016 - 2017) Analysis & Trends
Immuron's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at -$127500.4 for Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -127,500.44 |
| Dec 31, 2017 | -127,500.44 |
| Dec 31, 2016 | -101,915.21 |
| Dec 31, 2016 | -101,915.21 |
| Jun 30, 2016 | -3,118.23 |
| Jun 30, 2016 | -3,118.23 |